Sugi Predict

Sugi Predict / Compounds / SCHEMBL19901689

SCHEMBL19901689

SCHEMBL19901689

COc1ccc(C(=O)N[C@@H](N)COc2cccc3nc(C)c(C(=O)O)c(N)c23)cc1OCCCO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMPD1 P17405 6/20 0.38
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PDE4D Q08499 3/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SCD O00767 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ PDE4A P27815 2/20 0.35
▸ PDE4B Q07343 2/20 0.35
▸ PDE4C Q08493 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19901675 0.97 MEN1 (0.37) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL20857162 0.96 SCD (0.38) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL619358 0.93 POLB (0.39) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL618525 0.93 POLB (0.39) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL20857173 0.93 MAPT (0.37) MAPTSMN1; SMN2MEN1KMT2APOLB
SCHEMBL618195 0.90 POLB (0.39) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL618196 0.90 POLB (0.39) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL621642 0.89 POLB (0.41) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL618508 0.89 POLB (0.41) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL618926 0.89 TAS1R3 (0.37) SMPD1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11129397-B2 Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer FIREMENICH INCORPORATED (US) 2021-09-28 — — US disclosed
US-20190208802-A1 METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER FIRMENICH INCORPORATED 2019-07-11 — — US disclosed
US-10244779-B2 Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer SENOMYX, INC. (US) 2019-04-02 — — US disclosed
US-9902737-B2 Sweet flavor modifier SENOMYX, INC. (US) 2018-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10244779-B2 Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer TFEB, TREH, SLC2A8 SMPD1 1862/4885MAPT 1864/4885SMN1; SMN2 101/4885
US-11129397-B2 Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer TFEB, TREH, SLC2A8 SMPD1 1862/4885MAPT 1864/4885SMN1; SMN2 101/4885
US-20190208802-A1 METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER TFEB, TREH, SLC2A8 SMPD1 1862/4885MAPT 1864/4885SMN1; SMN2 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.